Wednesday, July 8, 2026

pharma · Retinitis Pigmentosa · Dry Eye Disease · KPRX

KIORA PHARMACEUTICALS

KIORA PHARMACEUTICALS trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Encinitas, USA HQ
2013 Founded
18 Employees
Public company Type
KPRX · NYSE Ticker
Company details
Status
Public
HQ
Encinitas, USA
Founded
2013
Employees
18
Programs
5
Drugs
4
Patents
4
Intelligence · Clinical Trials

KIORA PHARMACEUTICALS clinical trials

Registry index of 5 ClinicalTrials.gov studies linked to KIORA PHARMACEUTICALS programs — each row shows trial ID, program name, phase, status, and indication.

KIORA PHARMACEUTICALS trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

5 updates

Latest clinical program signals indexed for KIORA PHARMACEUTICALS.

  1. OBG PED-001 — Phase 2

    Clinical update
  2. 100 μg KIO-301 — Phase 2

    Clinical update
  3. KIO-104 — Phase 2

    Clinical update
  4. KIO-101 — Phase 2

    Clinical update
  5. KIO-301 — Phase 2

    Clinical update

Trial registry

5 studies